Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Activation of mGluR5 site-specifically decreases spine density in the nucleus accumbens. by Kellie S. Gross (3115299)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

Decreased cellular infiltration into lungs of <i>Ifi35</i> deficient mice after H5N1-VN/PR8 infection. by Anshu P. Gounder (626041)

Cobalt decreases the expression of AQP5 expression in MLE-12 cells. by Jitesh D. Kawedia (384551)

Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum. by Kellie S. Gross (3115299)

“…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”

Overexpression of PR decreases Myc expression and activity. by Tamar Kavlashvili (849072)

SARS-CoV-2 inhibits SG formation and decreases expression of G3BP1. by Stacia M. Dolliver (13822801)

Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins in <i>Neisseria gonorrh... by Joshua Tomberg (1345956)

“…Transfer of the mosaic <i>penA35</i> allele containing an A501V mutation to FA6140, a chromosomally mediated penicillin-resistant isolate, increased the MICs of ceftriaxone (0.4 μg/mL) and cefixime (1.2 μg/mL) to levels above their respective break points. …”

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

Subjects:

LRP deficiency in MΦ's results in normal IFN-γ response but decreased IL-4. by Roman Covarrubias (602292)

Decrease of viral load and ALT at different time points under treatment according to NS5A-inhibitors and interferon administration. by Valeria Cento (103603)

A multicopy <i>ASH1</i> plasmid increases <i>ASH1</i> mRNA and decreases <i>HO</i> mRNA levels. by Emily J. Parnell (6803422)

“…<i>ASH1</i> mRNA analysis under conditions of <i>ASH1</i> overexpression, using cell samples identical to those in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009133#pgen.1009133.g001" target="_blank">Fig 1E</a> (Tup1-V5 ChIP analysis). …”

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

Decreased expression of HATL5 mRNA and protein in human carcinomas. by Gregory S. Miller (519005)

Decreasing medium osmolarity causes retraction as theoretically predicted. by Nikola Ojkic (651966)

Is the only transcript decreasing in cells following tunicamycin treatment by Maho Niwa (7152)

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

Cell growth and viability decrease confirmed by growth inhibition in HepG3. by Arlet Hernandez (12289155)